Alliance Pharma To Acquire Cambridge Laboratories

Alliance Pharma has conditionally agreed to acquire Cambridge Laboratories (Ireland) and Cambridge Laboratories (together the ‘Vendors’), for total consideration of between £14.3m and £16.4m, plus the value of inventory held by the Vendors at completion. The acquisition is expected to be completed on 22 February, 2010.

Related posts:

1. Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs
2. Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services
3. Galapagos, MorphoSys Add One More Antibody To Alliance